Skip to main content

Table 2 Description of the Confirmed COVID-19 cases

From: Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD

Case # Age Sex Comorbidities Disease Duration Walking Disability score Rituximab injections times Extended Interval Dosing Recent exacerbation Recent corticosteroid use Self-isolation COVID-19 Exposure Treatment method Admission duration Consequence
1 42 Male No 13 1 Twice No No No No Yes Hospital admission <  2 weeks Death
2 59 Male No 4 1 >  4 times No No No No Yes Hospital admission
(ICU)
<  2 weeks Death
3 64 Female No 4 1 Twice Yes No No No Yes Home care N/A Cured
4 41 Male No 12 1 >  4 times No No No Yes No Home care N/A Cured
5 46 Female No 4 2 >  4 times No No No Yes No Hospital admission <  2 weeks Cured
6 49 Female No 8 2 >  4 times No No No Yes Yes Hospital admission
(ICU)
<  2 weeks Cured
7 42 Male No 15 2 >  4 times No No No Yes No Hospital admission <  2 weeks Cured
8 52 Female No 6 1 Twice No No No Yes No Home care N/A Cured
9 48 Female No 18 5 >  4 times Yes No Yes Yes No Home care N/A Cured